The enhancement of immunoactivity induced by immunogenic cell death through serine/threonine kinase 10 inhibition: a potential therapeutic strategy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xiaoli,Xia

第一单位： Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital, School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.

作者： Xiaoli,Xia ^[1] ; Yixin,Wang ^[1] ; Minghui,Wang ^[1] ; Jian,Lin ^[1] ; Ruiheng,Wang ^[1] ; Shufeng,Xie ^[1] ; Yaoyifu,Yu ^[1] ; Jinlan,Long ^[1] ; Zixuan,Huang ^[1] ; Huajian,Xian ^[1] ; Wenjie,Zhang ^[1] ; Chaoqun,Lu ^[1] ; Wenfang,Wang ^[1] ; Han,Liu ^[1]

作者单位： Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital, School of Medicine and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China. ^[1]

关键词 ICD inducer ICD-high subtype ICD-low subtype STK10 prognosis

主题词人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);动物(Animals);小鼠(Mice);预后(Prognosis);细胞系, 肿瘤(Cell Line, Tumor);蛋白激酶抑制剂(Protein Kinase Inhibitors)

DOI 10.3389/fimmu.2024.1451796

PMID 39555062

发布时间 2024-11-19

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交